Results 171 to 180 of about 966,197 (400)

Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes

Vascular Health and Risk Management, 2010
Magnus Dencker1, Martin Stagmo2, Mozhgan Dorkhan31Unit of Clinical Physiology and Nuclear Medicine, Department of Clinical Sciences, 2Division of Cardiology, 3Division of Diabetes and Endocrinology, Malmö University Hospital, Malm&ouml ...
Magnus Dencker, Martin Stagmo, Mozhgan Dorkhan   +2 more
doaj  

Role of Plasma B-type Natriuretic Peptide in Diagnosing Heart Failure

, 1970
Mohammed Saiful Alam, DHMS Sirajul Haque, Md Nurul Amin   +2 more
openalex   +2 more sources

The vasodilator potency of atrial natriuretic peptide in man. [PDF]

, 1987
Peter Bolli, Franco Müller, Lilly Linder, A. E. G. Raine, Thérèse J. Resink, Paul Erné, Wolfgang Kiowski, R Ritz, Fritz R. Bühler   +8 more
openalex   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Developmental roles of natriuretic peptides and their receptors. [PDF]

Cells Dev, 2023
Juraver-Geslin H, Devotta A, Saint-Jeannet JP.   +2 more
europepmc   +1 more source

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases

Российский кардиологический журнал
Currently, natriuretic peptides (including brain natriuretic peptide (BNP)) are widely used in clinical practice as biomarkers for various cardiovascular diseases.
A. Ya. Panarina, G. I. Lifshits
doaj   +1 more source

The renal action of atrial natriuretic peptide during control of glomerular filtration

, 1986
John C. Burnett, Terry J. Opgenorth, Joey P. Granger   +2 more
openalex   +1 more source

Immunoreactive atrial natriuretic peptide in ventricles, atria, hypothalamus, and plasma of genetically hypertensive rats. [PDF]

, 1988
Heikki Ruskoaho, Juhani Leppäluoto
openalex   +1 more source

The natriuretic peptide family [PDF]

European Journal of Clinical Investigation, 1995
Garry McDowell, K. D. Buchanan, Christopher Shaw, D. P. Nicholls   +3 more
openaire   +2 more sources